|

XNW28012 Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • Evopoint Biosciences Inc.1

Indications

  • Cervical Cancers1
  • Advanced Solid Tumors1
  • Ovarian Cancer1
  • Pancreatic Carcinoma1
  • Cancer1

Other1 trial

Study of XNW28012 in Subjects with Advanced Solid Tumors Who Failed Standard Treatments
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.